Contact
Please use this form to send email to PR contact of this press release:
Closing of Second Tranche of Private Placement Financing, Amendment to Terms of Secured Debt and Director Change
TO:
MARK A UPSDELL
Rapid Dose Therapeutics Corp.
+1 416-477-1052